Literature DB >> 22209659

Incidence of synchronous liver metastases in patients with colorectal cancer in relationship to clinico-pathologic characteristics. Results of a German prospective multicentre observational study.

R Mantke1, U Schmidt, S Wolff, R Kube, H Lippert.   

Abstract

BACKGROUND: The aim of this prospective observational multicentre study was to evaluate the incidence of synchronous liver metastases in colon and rectal cancer and to determine clinico-pathologic factors of the colorectal cancer that influenced the development of synchronous liver metastases.
METHODS: Of 48,894 patients with colorectal cancer and who underwent surgery between January 2000 and December 2004, 7209 developed hepatic metastases and were analyzed.
RESULTS: Synchronous liver metastases occurred in 14.7% of the colorectal cancer cases. Colon cancer (15.4%) led significantly more frequently to haematogenous spread to the liver than rectal cancer (13.5%) in a univariate approach. The N, V, and T stage, as well as the number of metastatic-involved local lymph nodes independently influenced the frequency of synchronous liver metastases in colon and rectal cancer in a multivariate analysis. Localization of the cancer in the colon led to a different number of synchronous liver metastases. Localization of the rectal cancer did not influence the rate of synchronous liver metastases. In the case of synchronous liver metastases, patients with colon cancer had significantly more peritoneal metastases (17.9 vs. 9.15%) but less lung (9.7 vs. 14%) and bone (0.7 vs. 1.6%) metastases. Simultaneous curative liver resections were done in 7% of colon cancer cases and in 8.8% of rectal cancer cases.
CONCLUSION: In this national study the incidence of synchronous liver metastases in colon and rectal cancer were different. Independent factors leading to synchronous liver metastases could be identified. Venous infiltration seems to be important for the development of distant metastases.
Copyright © 2011 Elsevier Ltd. All rights reserved.

Entities:  

Mesh:

Year:  2011        PMID: 22209659     DOI: 10.1016/j.ejso.2011.12.013

Source DB:  PubMed          Journal:  Eur J Surg Oncol        ISSN: 0748-7983            Impact factor:   4.424


  18 in total

1.  Positron emission tomography/computed tomography and biomarkers for early treatment response evaluation in metastatic colon cancer.

Authors:  Bodil E Engelmann; Annika Loft; Andreas Kjær; Hans J Nielsen; Thomas A Gerds; Eric V Benzon; Nils Brünner; Ib J Christensen; Susanne H Hansson; Niels H Holländer; Michael H Kristensen; Johan Löfgren; Elena Markova; Carsten Sloth; Liselotte Højgaard
Journal:  Oncologist       Date:  2014-01-22

2.  The Nd:YAG LIMAX® 120 high-output laser: local effects and resection capacity on liver parenchyma.

Authors:  Andreas Kirschbaum; P Rexin; D K Bartsch; P Di Fazio
Journal:  Lasers Med Sci       Date:  2014-02-22       Impact factor: 3.161

Review 3.  The management of rectal cancer with synchronous liver metastases: a modern surgical dilemma.

Authors:  A A P Slesser; A Bhangu; G Brown; S Mudan; P P Tekkis
Journal:  Tech Coloproctol       Date:  2012-09-26       Impact factor: 3.781

4.  Establishment of a new non-invasive imaging prediction model for liver metastasis in colon cancer.

Authors:  Yu Li; Aydin Eresen; Junjie Shangguan; Jia Yang; Yun Lu; Dong Chen; Jian Wang; Yury Velichko; Vahid Yaghmai; Zhuoli Zhang
Journal:  Am J Cancer Res       Date:  2019-11-01       Impact factor: 6.166

5.  Recurrence After Partial Hepatectomy for Metastatic Colorectal Cancer: Potentially Curative Role of Salvage Repeat Resection.

Authors:  Jean M Butte; Mithat Gönen; Peter J Allen; T Peter Kingham; Constantinos T Sofocleous; Ronald P DeMatteo; Yuman Fong; Nancy E Kemeny; William R Jarnagin; Michael I D'Angelica
Journal:  Ann Surg Oncol       Date:  2015-01-09       Impact factor: 5.344

6.  Salvage RFA in patients with intrahepatic recurrence after major hepatic surgery for colorectal cancer liver metastases: mid-term outcome.

Authors:  Markus Zimmermann; Federico Pedersoli; Maximilian Schulze-Hagen; Georg Lurje; Peter Isfort; Christiane Kuhl; Philipp Bruners
Journal:  Eur Radiol       Date:  2019-09-06       Impact factor: 5.315

7.  Systemic treatment of liver metastases from colorectal cancer.

Authors:  Alexander Stein; Hans-Joachim Schmoll
Journal:  Ther Adv Med Oncol       Date:  2013-05       Impact factor: 8.168

Review 8.  The tumour biology of synchronous and metachronous colorectal liver metastases: a systematic review.

Authors:  A A P Slesser; P Georgiou; G Brown; S Mudan; R Goldin; P Tekkis
Journal:  Clin Exp Metastasis       Date:  2012-11-23       Impact factor: 5.150

9.  Short course radiation as a component of definitive multidisciplinary treatment for select patients with metastatic rectal adenocarcinoma.

Authors:  Emma B Holliday; Andrew Hunt; Y Nancy You; George J Chang; John M Skibber; Miguel A Rodriguez-Bigas; Brian K Bednarski; Cathy Eng; Eugene J Koay; Bruce D Minsky; Cullen Taniguchi; Sunil Krishnan; Joseph M Herman; Prajnan Das
Journal:  J Gastrointest Oncol       Date:  2017-12

10.  Expression of HGF and Met in human tissues of colorectal cancers: biological and clinical implications for synchronous liver metastasis.

Authors:  Yan-lai Sun; Wei-dong Liu; Guo-yuan Ma; Dong-wei Gao; Yuan-zhu Jiang; Qi Liu; Jia-jun Du
Journal:  Int J Med Sci       Date:  2013-03-15       Impact factor: 3.738

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.